<?xml version="1.0" encoding="UTF-8" ?><!-- Generated on Sun, 05 Apr 2026 07:24:00 -0400--><rss version="2.0">
    <channel>
        <title>Sigyn Therapeutics, Inc. (SIGY) Press Releases</title>
        <link>https://www.sigyntherapeutics.com/news-media/press-releases/rss</link>
        <description>Please specify a description for this RSS Feed</description>
        <language>en-us</language>
                                            <image>
                <url>https://d1io3yog0oux5.cloudfront.net/sigyntherapeutics/files/theme/images/logo-sm.png</url>
                <title>Sigyn Therapeutics, Inc. Logo</title>
                <link>https://www.sigyntherapeutics.com</link>
            </image>
                <generator>Equisolve Investor Relations Suite</generator>
        
                            <item>
                <title><![CDATA[Sigyn Therapeutics Launches Initiative to Evaluate Emerging Medical Technologies in Former NFL Players at Risk of CTE]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/122/sigyn-therapeutics-launches-initiative-to-evaluate-emerging</link>
                <pubDate>Thu, 02 Apr 26 07:57:00 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/122/sigyn-therapeutics-launches-initiative-to-evaluate-emerging</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[CardioDialysisTM, a Next-Generation Technology to Reduce Major Adverse Cardiovascular Events]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/121/cardiodialysistm-a-next-generation-technology-to-reduce</link>
                <pubDate>Fri, 27 Mar 26 10:19:00 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/121/cardiodialysistm-a-next-generation-technology-to-reduce</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Scientific American Highlights Scientific Discovery That Supports the Potential Use of CardioDialysis(TM) to Treat Neuroinflammatory Diseases]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/120/scientific-american-highlights-scientific-discovery-that</link>
                <pubDate>Tue, 24 Mar 26 07:56:00 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/120/scientific-american-highlights-scientific-discovery-that</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Sigyn Therapeutics Issues Shareholder Update Regarding Potential Merger and Asset Sale Initiatives]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/119/sigyn-therapeutics-issues-shareholder-update-regarding</link>
                <pubDate>Fri, 13 Mar 26 11:42:00 -0400</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/119/sigyn-therapeutics-issues-shareholder-update-regarding</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Sigyn Therapeutics Issues Shareholder Update Highlighting the Advancement of CardioDialysis(TM) and New Corporate Initiatives]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/118/sigyn-therapeutics-issues-shareholder-update-highlighting</link>
                <pubDate>Thu, 15 Jan 26 10:52:00 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/118/sigyn-therapeutics-issues-shareholder-update-highlighting</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[The Emergence of Blood Purification Devices to Treat Cardiovascular Disease]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/117/the-emergence-of-blood-purification-devices-to-treat</link>
                <pubDate>Tue, 06 Jan 26 17:01:00 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/117/the-emergence-of-blood-purification-devices-to-treat</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Sigyn CEO Note: First-In-Industry Attributes of CardioDialysisTM to Treat Cardiovascular Disease]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/116/sigyn-ceo-note-first-in-industry-attributes-of</link>
                <pubDate>Thu, 11 Dec 25 11:38:00 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/116/sigyn-ceo-note-first-in-industry-attributes-of</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Sigyn CEO Note: Nature Publication Reinforces Rationale for CardioDialysisTM to Address Cardiovascular Disease in Dialysis Patients]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/115/sigyn-ceo-note-nature-publication-reinforces-rationale-for</link>
                <pubDate>Wed, 03 Dec 25 07:51:00 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/115/sigyn-ceo-note-nature-publication-reinforces-rationale-for</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Sigyn CardioDialysis(TM) Featured on the Big Biz Show]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/114/sigyn-cardiodialysistm-featured-on-the-big-biz-show</link>
                <pubDate>Tue, 18 Nov 25 07:51:00 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/114/sigyn-cardiodialysistm-featured-on-the-big-biz-show</guid>
                                                                            </item>
                    <item>
                <title><![CDATA[Sigyn Therapeutics Reports Third Quarter Financial Results and Subsequent Introduction of CardioDialysis(TM)]]></title>
                <description><![CDATA[]]></description>
                <link>https://www.sigyntherapeutics.com/news-media/press-releases/detail/113/sigyn-therapeutics-reports-third-quarter-financial-results</link>
                <pubDate>Fri, 14 Nov 25 17:07:00 -0500</pubDate>
                <guid isPermalink="true">https://www.sigyntherapeutics.com/news-media/press-releases/detail/113/sigyn-therapeutics-reports-third-quarter-financial-results</guid>
                                                                            </item>
            </channel>
</rss>